WaferGen Bio-systems, Inc. (WaferGen) is engaged in the development, manufacture and sale of genomic technology solutions for single-cell analysis (SCA) and clinical research. The Company focuses on marketing an open format genetic analysis system, the WaferGen SmartChip System. The Company's ICELL8 Single-Cell System is a platform that can isolate a range of single cells and process specific cells for analysis, including Next Generation Sequencing (NGS). ICELL8 is based upon the Company's SmartChip platform, which is also used for profiling and validating molecular biomarkers. The Company's SmartChip is a micro-fabricated chip comprising a range of massively-parallel micro wells that are physically separated from each other. It offers SmartChip System Capabilities, SmartChip Single-Cell Isolation System, SmartChip Target Enrichment (TE) System and Apollo 324 Library Preparation.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Diagnostic & Testing Equipment
- Sub-Industry: N/A
- Symbol: NASDAQ:WGBS
- CUSIP: N/A
- Web: www.wafergen.com/
Average Prices:- 50 Day Moving Avg: $5.96
- 200 Day Moving Avg: $2.96
- 52 Week Range: $0.50 - $7.00
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -3.73
- P/E Growth: 0.00
Profitability:- Net Margins: -153.30%
- Return on Equity: -463.27%
- Return on Assets: -111.39%
Debt:- Debt-to-Equity Ratio: 1.90%
- Current Ratio: 1.82%
- Quick Ratio: 1.53%
Misc:- Average Volume: 59,700 shs.
- Beta: 1.29
Frequently Asked Questions for WaferGen Bio-systems (NASDAQ:WGBS)
What is WaferGen Bio-systems' stock symbol?
WaferGen Bio-systems trades on the NASDAQ under the ticker symbol "WGBS."
How were WaferGen Bio-systems' earnings last quarter?
WaferGen Bio-systems, Inc. (NASDAQ:WGBS) announced its quarterly earnings data on Tuesday, August, 9th. The company reported ($0.26) earnings per share for the quarter, missing analysts' consensus estimates of ($0.18) by $0.08. The firm earned $2.50 million during the quarter, compared to analysts' expectations of $2.60 million. WaferGen Bio-systems had a negative return on equity of 463.27% and a negative net margin of 153.30%. View WaferGen Bio-systems' Earnings History.
Who are some of WaferGen Bio-systems' key competitors?
Some companies that are related to WaferGen Bio-systems include Partnership Assurance Group PLC (PA), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Shire PLC (SHP), Teva Pharmaceutical Industries Ltd (TEVA), Hospira (HSP), Smith & Nephew plc (SN), Omnicare (OCR), Valeant Pharmaceuticals Intl (VRX), NMC Health PLC (NMC), ConvaTec Group PLC (CTEC), Health Net (HNT), Catalent (CTLT), Patheon NV (PTHN), Mediclinic International PLC (MDC), Puma Biotechnology (PBYI), Cotiviti Holdings (COTV) and WuXi PharmaTech (Cayman) (WX).
How do I buy WaferGen Bio-systems stock?
Shares of WaferGen Bio-systems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is WaferGen Bio-systems' stock price today?
One share of WaferGen Bio-systems stock can currently be purchased for approximately $6.90.
MarketBeat Community Rating for WaferGen Bio-systems (NASDAQ WGBS)MarketBeat's community ratings are surveys of what our community members think about WaferGen Bio-systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for WaferGen Bio-systems (NASDAQ:WGBS) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for WaferGen Bio-systems (NASDAQ:WGBS)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 3/14/2016 | Ladenburg Thalmann Financial Services | Lower Price Target | Buy | $6.00 -> $5.00 | N/A |  |
(Data available from 9/22/2015 forward)
Earnings History for WaferGen Bio-systems (NASDAQ:WGBS)Earnings History by Quarter for WaferGen Bio-systems (NASDAQ WGBS)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/8/2016 | Q3 | ($0.13) | ($0.19) | $2.50 million | $2.40 million | View | Listen | |
| 8/9/2016 | Q216 | ($0.18) | ($0.26) | $2.60 million | $2.50 million | View | N/A | |
| 5/10/2016 | Q1 | ($0.23) | ($0.24) | | $1.93 million | View | Listen | |
| 3/8/2016 | Q4 | ($0.29) | ($0.25) | | $2.40 million | View | N/A | |
| 11/10/2015 | Q315 | ($0.61) | ($0.61) | $2.00 million | $2.00 million | View | N/A | |
| 8/5/2015 | Q215 | ($0.65) | ($0.67) | $2.10 million | $1.60 million | View | N/A | |
| 3/16/2015 | | ($0.56) | ($0.62) | | $1.61 million | View | N/A | |
| 11/7/2014 | Q314 | | ($1.32) | | $1.30 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for WaferGen Bio-systems (NASDAQ:WGBS)Current Year EPS Consensus Estimate: $-4.30 EPS
Next Year EPS Consensus Estimate: $-1.85 EPS
Dividend History for WaferGen Bio-systems (NASDAQ:WGBS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for WaferGen Bio-systems (NASDAQ:WGBS)Insider Ownership Percentage: 5.78%
Institutional Ownership Percentage: 49.77%
Insider Trades by Quarter for WaferGen Bio-systems (NASDAQ:WGBS)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 9/24/2015 | Awm Investment Company, Inc. | Major Shareholder | Sell | 505,282 | $2.10 | $1,061,092.20 | |
| 9/22/2015 | Awm Investment Company, Inc. | Major Shareholder | Sell | 492,373 | $2.31 | $1,137,381.63 | |
(Data available from 1/1/2013 forward)
Headline Trends for WaferGen Bio-systems (NASDAQ:WGBS)
Latest Headlines for WaferGen Bio-systems (NASDAQ:WGBS)
| Source: |
|
WaferGen Bio-systems (WGBS) Chart for Friday, September, 22, 2017
